About us
The FAILSAFE project, led by the University of Exeter’s MRC Centre for Medical Mycology (MRC CMM) and funded by the UK Department of Health’s Global AMR Innovation Fund, addresses the growing threat of antifungal resistance (AFR).
Funded Research
In its first funding wave, FAILSAFE supported 78 researchers across 13 countries to accelerate solutions for this global issue, which heavily impacts low- and middle-income countries (LMICs).
Members
The CMM-FAILSAFE Medical Mycology Network seeks to facilitate and enhance global mycology research and development (R&D) aimed at advancing knowledge on fungal pathogens and diseases they cause as well as reducing the threat of anti-fungal resistance for the benefit of people in LMICs.
Products and Solutions
At FAILSAFE, we are committed to helping our awarded researchers transform their ideas and discoveries into viable products and solutions that can have a lasting impact on public health, particularly in low- and middle-income countries. Our focus is on fungal AMR, and we support researchers at every stage of the journey from concept to commercialisation.
